- Home
- AQST vs FBYD Comparison
AQST vs FBYD Comparison
Compare AQST & FBYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- FBYD
- Stock Information
- Founded
- AQST 2004
- FBYD 2021
- Country
- AQST United States
- FBYD United States
- Employees
- AQST N/A
- FBYD N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- FBYD
- Sector
- AQST Health Care
- FBYD
- Exchange
- AQST Nasdaq
- FBYD Nasdaq
- Market Cap
- AQST 254.1M
- FBYD 300.5M
- IPO Year
- AQST 2018
- FBYD N/A
- Fundamental
- Price
- AQST $2.79
- FBYD $7.78
- Analyst Decision
- AQST Strong Buy
- FBYD
- Analyst Count
- AQST 5
- FBYD 0
- Target Price
- AQST $11.40
- FBYD N/A
- AVG Volume (30 Days)
- AQST 939.1K
- FBYD 17.3K
- Earning Date
- AQST 05-12-2025
- FBYD 05-19-2025
- Dividend Yield
- AQST N/A
- FBYD N/A
- EPS Growth
- AQST N/A
- FBYD N/A
- EPS
- AQST N/A
- FBYD 1.41
- Revenue
- AQST $57,561,000.00
- FBYD $6,745,000.00
- Revenue This Year
- AQST N/A
- FBYD N/A
- Revenue Next Year
- AQST $39.51
- FBYD N/A
- P/E Ratio
- AQST N/A
- FBYD $5.45
- Revenue Growth
- AQST 13.79
- FBYD N/A
- 52 Week Low
- AQST $2.20
- FBYD $3.62
- 52 Week High
- AQST $5.80
- FBYD $13.25
- Technical
- Relative Strength Index (RSI)
- AQST 49.93
- FBYD 53.88
- Support Level
- AQST $2.59
- FBYD $6.48
- Resistance Level
- AQST $3.05
- FBYD $8.00
- Average True Range (ATR)
- AQST 0.16
- FBYD 0.81
- MACD
- AQST 0.00
- FBYD 0.08
- Stochastic Oscillator
- AQST 43.57
- FBYD 88.67
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About FBYD Falcon's Beyond Global Inc.
Falcons Beyond Global Inc. is a Company that provides a full range of theme park design, master planning, and experiential technologies for customers in the entertainment and attraction industry through its Falcon's Creative Group reportable segment and develops and co-owns resort and theme park attractions through its Destinations Operations. The Company has five operating segments, Falcon's Creative Group, PDP, Sierra Parima, Falcon's Beyond Brands, and Destinations Operations, all of which are reportable segments. It earns the majority of the revenue from Falcon's Creative Group segment.